ArticleSexually transmitted infections1999
Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population.
Article in Sexually transmitted infections, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 104 citations in OpenAlex.
- HSV, HIV, and Pregnancy: Epidemiology, Viral Interactions, Management, and Prevention.Current HIV/AIDS reports · 2026Review
- Herpes Simplex Virus Type 2 (HSV-2) and Cytomegalovirus (CMV) among Women with Macerated Stillbirth: A Cross-Sectional Hospital-Based Study from Mwanza, Tanzania.Journal of pregnancy · 2022Article
- Point-of-care diagnostics: needs of African health care workers and their role combating global antimicrobial resistance.International journal of STD & AIDS · 2019Article
- HIV prevalence by ethnic group covaries with prevalence of herpes simplex virus-2 and high-risk sex in Uganda: An ecological study.PloS one · 2018Article
- Epidemiological impact of a syphilis vaccine: a simulation study.Epidemiology and infection · 2016Article
- Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda.BMC infectious diseases · 2015Article
- Article
- Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda.African health sciences · 2014Article
- Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2.Journal of virology · 2014Article
- Incidence of herpes simplex virus type 2 infections in Africa: a systematic review.Open forum infectious diseases · 2014Review
- HIV Infection in Uncircumcised Men Is Associated With Altered CD8 T-cell Function But Normal CD4 T-cell Numbers in the Foreskin.The Journal of infectious diseases · 2014Article
- The Syndromic versus Laboratory Diagnosis of Sexually Transmitted Infections in Resource-Limited Settings.ISRN AIDS · 2014Article
- Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007.Tropical medicine & international health : TM & IH · 2013Article
- The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies.International journal of epidemiology · 2013Article
- Article
- Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.Sexually transmitted diseases · 2010Article
- The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth.BMC women's health · 2010Article
- Association of age at first sex with HIV-1, HSV-2, and other sexual transmitted infections among women in northern Tanzania.Sexually transmitted diseases · 2009Article
- HIV prevalence and associated risk factors among individuals aged 13-34 years in Rural Western Kenya.PloS one · 2009Article
- New insights on interactions between HIV-1 and HSV-2.Current infectious disease reports · 2009Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo determine age-sex specific seroprevalence and incidence rates of Treponema pallidum, Haemophilus ducreyi, and HSV-2; to assess the association between HIV-1 status and incidence of these STIs; and HSV-2 serostatus with number of lifetime sexual partners.
methodsAntibodies against HIV-1, T pallidum, H ducreyi, and HSV-2 infections were tested using approximately 1000 paired (2 year interval) sera collected from a rural adult (15-54 years) population cohort in south west Uganda.
resultsOverall HIV-1 prevalence was 4.9%. Prevalence for T pallidum was 12.9% among males and 12.6% among females. The corresponding rates for H ducreyi were 9.8% and 7.3% respectively. HSV-2 prevalence rates were considerably lower in males (36.0%) than in females (71.5%), p < 0.001. Incidence rates for T pallidum per 1000 person years of observation were 8.4 for males and 12.3 for females. The corresponding rates for H ducreyi were 24.6 and 20.0 and for HSV-2 were 73.2 and 122.9 per 1000 person years of observation, respectively. The RR of HSV-2 incidence was 3.69 in HIV seropositive cases versus HIV seronegative after adjusting for age and sex. The corresponding RR for H ducreyi was 3.50 among female HIV positive cases versus negatives with no effect seen in males. Association between HIV-1 prevalence and prevalence of other STIs was significant (Mantel-Haenszel test) for H ducreyi (p = 0.01) and for HSV-2 (p = 0.004) but not for T pallidum (p > 0.4). HSV-2 prevalence was associated with number of lifetime sexual partners (females, p = 0.003; males, p = 0.08).
conclusionsThe results have provided a reliable estimate of the magnitude of the STI problem and demonstrated an association between HIV-1 status and serology of other STIs in a general rural population in sub-Saharan Africa. The study has also highlighted a correlation between HSV-2 seropositivity and number of reported lifetime sexual partners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.